Skip to main content
Top
Published in: Clinical Rheumatology 5/2006

01-09-2006 | Case Report

Simultaneous deep vein thrombosis and transverse myelitis with negative serology as a first sign of antiphospholipid syndrome: a case report and review of the literature

Authors: Dan Carter, David Olchovsky, Hagit Yonath, Pnina Langevitz, David Ezra

Published in: Clinical Rheumatology | Issue 5/2006

Login to get access

Abstract

Transverse myelitis is a rare manifestation of antiphospholipid syndrome, usually secondary to systemic lupus erythematosus (Rheum Dis Clin North Am 20:129–158, 1994). Only about 110 reports of this complication have been reported (Lupus 10:851–856, 2001). A connection has been demonstrated between positive serology for antiphospholipid and transverse myelitis (Lupus 8:109–115, 1999). Herein, we report of a young patient admitted with deep vein thrombosis and neurological manifestations of transverse myelitis with negative serology for systemic lupus erythematosus and antiphospholipid, who developed positive anticardiolipin antibody during pulse therapy with cyclophosphamide and methylprednisolone.
Literature
1.
go back to reference West SG (1994) Neuropsychiatric lupus. Rheum Dis Clin North Am 20:129–158PubMed West SG (1994) Neuropsychiatric lupus. Rheum Dis Clin North Am 20:129–158PubMed
2.
go back to reference Tellez-Zenteno JF, Remes-Troche JM, Negrete-Pulido RO, Davila-Maladonado L (2001) Longitudinal myelitis associated with systemic lupus erythematosis: clinical features and magnetic resonance imaging of six cases. Lupus 10:851–856CrossRefPubMed Tellez-Zenteno JF, Remes-Troche JM, Negrete-Pulido RO, Davila-Maladonado L (2001) Longitudinal myelitis associated with systemic lupus erythematosis: clinical features and magnetic resonance imaging of six cases. Lupus 10:851–856CrossRefPubMed
3.
go back to reference Ijdo JW, Conti-Kelly AM, Greco P, Abedi M, Amos M, Provenzale JM, Greco TP (1999) Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illness: MS or APS. Lupus 8:109–115CrossRefPubMed Ijdo JW, Conti-Kelly AM, Greco P, Abedi M, Amos M, Provenzale JM, Greco TP (1999) Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illness: MS or APS. Lupus 8:109–115CrossRefPubMed
4.
5.
go back to reference Transverse Myelitis Consortium Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neuron 59:499–505 Transverse Myelitis Consortium Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neuron 59:499–505
6.
go back to reference Kovasc B, Lafferty TL, Brent LH, Dehoratius RJ (2000) Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59:120–124CrossRefPubMed Kovasc B, Lafferty TL, Brent LH, Dehoratius RJ (2000) Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59:120–124CrossRefPubMed
7.
go back to reference Barille L, Lavalle C (1992) Transverse myelitis in systemic lupus erythematosus—the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol 19(3):370–372PubMed Barille L, Lavalle C (1992) Transverse myelitis in systemic lupus erythematosus—the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol 19(3):370–372PubMed
8.
go back to reference Sherer Y, Hassin S, Ohry Y, Levy Y, Livneh A, Shoenfield Y, Langevitz P (2002) Transverse myelitis in patients with antiphospholipid antibodies—the importance of early diagnosis and treatment. Clin Rheumatol 21:207–210CrossRefPubMed Sherer Y, Hassin S, Ohry Y, Levy Y, Livneh A, Shoenfield Y, Langevitz P (2002) Transverse myelitis in patients with antiphospholipid antibodies—the importance of early diagnosis and treatment. Clin Rheumatol 21:207–210CrossRefPubMed
9.
go back to reference Boumpas DT, Patronas NJ, Dalakas MC, Hakim CA, Kippel JH, Balow JE (1990) Acute transverse myelitis in systemic lupus erythematosus; magnetic resonance imaging and review of literature. J Rheumatol 17:89–92PubMed Boumpas DT, Patronas NJ, Dalakas MC, Hakim CA, Kippel JH, Balow JE (1990) Acute transverse myelitis in systemic lupus erythematosus; magnetic resonance imaging and review of literature. J Rheumatol 17:89–92PubMed
10.
go back to reference Piper PG (1953) Disseminated lupus erythematosus with involvement of the spinal cord. JAMA 153:215–217 Piper PG (1953) Disseminated lupus erythematosus with involvement of the spinal cord. JAMA 153:215–217
11.
go back to reference Andrianakos AA, Duffy J, Suzuki M, Sharp JJ (1975) Transverse myelopathy in systemic lupus erythematosus: report of three cases and review of the literature. Ann Intern Med 83:616–624PubMed Andrianakos AA, Duffy J, Suzuki M, Sharp JJ (1975) Transverse myelopathy in systemic lupus erythematosus: report of three cases and review of the literature. Ann Intern Med 83:616–624PubMed
12.
go back to reference Oppenheimer S, Hoffmand B (1986) Optic neuritis and myelopathy in systemic lupus erythematosus. Can J Neurol Sci 13:129–132PubMed Oppenheimer S, Hoffmand B (1986) Optic neuritis and myelopathy in systemic lupus erythematosus. Can J Neurol Sci 13:129–132PubMed
13.
go back to reference Petri M (1994) Diagnosis of antiphospholipid antibodies. Rheum Dis Clin North Am 20:443–469PubMed Petri M (1994) Diagnosis of antiphospholipid antibodies. Rheum Dis Clin North Am 20:443–469PubMed
14.
go back to reference Tartaglino JM, Croul SE, Flanders AF, Sweency JD, Schwartzman RJ, Liam M, Armer A (1996) Idiopathic acute transverse myelitis: MR imaging findings. Radiology 201:661–669PubMed Tartaglino JM, Croul SE, Flanders AF, Sweency JD, Schwartzman RJ, Liam M, Armer A (1996) Idiopathic acute transverse myelitis: MR imaging findings. Radiology 201:661–669PubMed
15.
go back to reference Provenzale JM, Barborick DP, Gaensler EH, Robertson RI, Mercer B (1994) Lupus-related myelitis: serial MR findings. Am J Neuroradiol 15:1911–1917PubMed Provenzale JM, Barborick DP, Gaensler EH, Robertson RI, Mercer B (1994) Lupus-related myelitis: serial MR findings. Am J Neuroradiol 15:1911–1917PubMed
16.
go back to reference Chan KF, Boey ML (1996) Transverse myelopathy in SLE: clinical features and functional outcomes. Lupus 5:294–299PubMedCrossRef Chan KF, Boey ML (1996) Transverse myelopathy in SLE: clinical features and functional outcomes. Lupus 5:294–299PubMedCrossRef
17.
go back to reference Harisdangkul V, Doorenbos D, Subramony SH (1995) Lupus transverse myelopathy: better outcomes with early recognition and aggressive high dose intravenous corticosteroid pulse treatment. J Neurol 242:326–331CrossRefPubMed Harisdangkul V, Doorenbos D, Subramony SH (1995) Lupus transverse myelopathy: better outcomes with early recognition and aggressive high dose intravenous corticosteroid pulse treatment. J Neurol 242:326–331CrossRefPubMed
Metadata
Title
Simultaneous deep vein thrombosis and transverse myelitis with negative serology as a first sign of antiphospholipid syndrome: a case report and review of the literature
Authors
Dan Carter
David Olchovsky
Hagit Yonath
Pnina Langevitz
David Ezra
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0051-y

Other articles of this Issue 5/2006

Clinical Rheumatology 5/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine